The Glucose Biosensor Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 8.2 billion by 2034, registering a CAGR of 8.9%. This growth trajectory is underpinned by several factors including the rising prevalence of diabetes, advancements in biosensor technology, and increasing health awareness among consumers. The demand for continuous glucose monitoring (CGM) devices is...